-
Mashup Score: 1Pacing‐induced cardiomyopathy after leadless pacemaker implant: It's all about location, location, location - 7 month(s) ago
Click on the article title to read more.
Source: onlinelibrary.wiley.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
July 5, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR dual chamber (DR) leadless pacemaker system, the world’s first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle),…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Abbott Unveils Late-breaking Data Showing the World's First Dual-chamber Leadless Pacemaker Study Met All Three Primary Endpoints - 11 month(s) ago
May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device Exemption (IDE) study, a large-scale study to assess the world’s first dual-chamber leadless pacemaker, showing that the leadless pacemaker met its three prespecified primary endpoints for safety and performance. The data further suggests that AVEIR DR could offer new benefits for…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Early success of dual-chamber leadless pacemaker suggests big changes could be on the horizon - 11 month(s) ago
Daniel Cantillon, MD, explained why the positive performance of Abbott’s Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
May 22, 2023 — Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization therapy (CRT) among patients who were not able to be treated with conventional CRT and epicardial leads. The novel WiSE CRT system removes the possibility of lead complications and provides physicians with more freedom to target the pacing site within the endocardium of the…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Medtronic Receives FDA Approval for its Next Generation Micra Leadless Pacing Systems - 12 month(s) ago
May 1, 2023 — Medtronic plc, a global leader in healthcare technology, announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. Micra AV2 and Micra VR2, the world’s smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers,…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Wireless Pacemakers May be Safe, Effective for Children with Irregular Heart Rhythms - 1 year(s) ago
April 13, 2023 — Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal of the American Heart Association. Children with a heartbeat that is too slow (bradycardia) require pacemakers — devices…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Synchronous atrioventricular sequential pacing utilizing conventional and leadless pacemakers in an elderly patient: a case report - 1 year(s) ago
AbstractBackground. Leadless pacemakers present a viable alternative to conventional transvenous devices to mitigate the risk of lead- and/or pocket-related com
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2First-In-Human Use of the ŌNŌ Retrieval System for Percutaneous Removal of an Embolized Leadless Pacemaker from the Right Pulmonary Artery - 2 year(s) ago
September 13, 2022 — The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary artery in a 52- year-old patient, ŌNŌCOR LLC announced. The team at UCLA Medical Center, Los Angeles, California, percutaneously removed the wayward device from the patient using a combination of ŌNŌ, commercially available…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Bioelectronic medicine and it’s applications in cardiology - 2 year(s) ago
The history of bioelectronic medicine (BM) in cardiology is a tiara studded with emerald innovators, animated by impellent clinical needs. John ‘Jack’ Hopps, an
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
Please see accompanying editorial: When it comes to risk of #cardiomyopathy after #leadless #PPM, location matters! @DPipilasMD, @shaan_khurshid, @MGHHeartHealth https://t.co/dKtuiLE2eJ